Showing results (1051-1060 of 1,873) with videos related to
Sort By:
Pageof 188
Pulmonary Pharmacology & Therapeutics|July 21, 2009
Tobramycin for inhalation in cystic fibrosis: Beyond respiratory improvementsAlexander Chuchalin, Elena Amelina, Federico BiancoPulmonary Pharmacology & Therapeutics|September 16, 2009
Blockade of neutrophil responses in aspiration pneumonia via ELR-CXC chemokine antagonism does not predispose to airway bacterial outgrowthXixing Zhao, Jennifer R Town, Fang Li, et al.Pulmonary Pharmacology & Therapeutics|April 13, 2010
The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary diseaseArmin Hatzelmann, Esteban J Morcillo, Giuseppe Lungarella, et al.Pulmonary Pharmacology & Therapeutics|April 13, 2010
The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPDMario Cazzola, Mathieu MolimardPulmonary Pharmacology & Therapeutics|April 6, 2010
RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in miceBirgitt Gutbier, Stefanie M Kube, Katrin Reppe, et al.Pulmonary Pharmacology & Therapeutics|March 31, 2009
Matrix metalloproteinase 12 silencing: a therapeutic approach to treat pathological lung tissue remodeling?Nancy Garbacki, Emmanuel Di Valentin, Jacques Piette, et al.Pulmonary Pharmacology & Therapeutics|October 27, 2009
TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath waterMaria Gabriella Matera, Luigino Calzetta, Mario CazzolaPulmonary Pharmacology & Therapeutics|May 30, 2017
rHuKGF ameliorates protease/anti-protease imbalance in emphysematous miceSudhir Kotnala, Amit Tyagi, Jai Prakash MuyalPulmonary Pharmacology & Therapeutics|May 15, 2017
IL-13 and idiopathic pulmonary fibrosis: Possible links and new therapeutic strategiesGiovanni Passalacqua, Marcello Mincarini, Daniele Colombo, et al.Pageof 188